nodes	percent_of_prediction	percent_of_DWPC	metapath
Paricalcitol—CYP3A4—Pilocarpine—glaucoma	0.0747	0.235	CbGbCtD
Paricalcitol—CYP3A4—Brinzolamide—glaucoma	0.0586	0.185	CbGbCtD
Paricalcitol—CYP3A4—Dorzolamide—glaucoma	0.0566	0.178	CbGbCtD
Paricalcitol—CYP3A4—Methazolamide—glaucoma	0.0505	0.159	CbGbCtD
Paricalcitol—CYP3A4—Acetazolamide—glaucoma	0.0403	0.127	CbGbCtD
Paricalcitol—CYP3A4—Clonidine—glaucoma	0.0365	0.115	CbGbCtD
Paricalcitol—VDR—Direct p53 effectors—POU4F2—glaucoma	0.00325	0.0564	CbGpPWpGaD
Paricalcitol—UGT1A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.00275	0.0477	CbGpPWpGaD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—ABCA1—glaucoma	0.00243	0.0421	CbGpPWpGaD
Paricalcitol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.00234	0.0406	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.00196	0.034	CbGpPWpGaD
Paricalcitol—VDR—Ovarian Infertility Genes—CCND2—glaucoma	0.00193	0.0335	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—POU4F1—glaucoma	0.00178	0.0309	CbGpPWpGaD
Paricalcitol—CYP24A1—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.00148	0.0257	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.00147	0.0255	CbGpPWpGaD
Paricalcitol—CYP24A1—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.00146	0.0254	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors—NR3C1—glaucoma	0.00133	0.023	CbGpPWpGaD
Paricalcitol—VDR—Validated transcriptional targets of deltaNp63 isoforms—IL1A—glaucoma	0.00122	0.0211	CbGpPWpGaD
Paricalcitol—CYP24A1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.0012	0.0209	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—SLC6A13—glaucoma	0.00115	0.0199	CbGpPWpGaD
Paricalcitol—UGT1A4—Phase II conjugation—GSTT1—glaucoma	0.0011	0.019	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.00105	0.0182	CbGpPWpGaD
Paricalcitol—VDR—Validated transcriptional targets of TAp63 isoforms—FAS—glaucoma	0.000969	0.0168	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—TXN—glaucoma	0.000943	0.0164	CbGpPWpGaD
Paricalcitol—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000878	0.0152	CbGpPWpGaD
Paricalcitol—VDR—Ovarian Infertility Genes—CDKN1B—glaucoma	0.000878	0.0152	CbGpPWpGaD
Paricalcitol—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000859	0.0149	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—SLC6A1—glaucoma	0.00084	0.0146	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—glaucoma	0.000824	0.0143	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—GSTT1—glaucoma	0.000802	0.0139	CbGpPWpGaD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TNF—glaucoma	0.000739	0.0128	CbGpPWpGaD
Paricalcitol—VDR—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—glaucoma	0.000729	0.0126	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—NR3C1—glaucoma	0.000723	0.0126	CbGpPWpGaD
Paricalcitol—UGT1A4—Phase II conjugation—GSTM1—glaucoma	0.000698	0.0121	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—TGFB2—glaucoma	0.000685	0.0119	CbGpPWpGaD
Paricalcitol—VDR—Validated transcriptional targets of TAp63 isoforms—CDKN2A—glaucoma	0.000652	0.0113	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—GSTT1—glaucoma	0.000641	0.0111	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—CYP1B1—glaucoma	0.000639	0.0111	CbGpPWpGaD
Paricalcitol—CYP24A1—Metapathway biotransformation—CYP1B1—glaucoma	0.00063	0.0109	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000626	0.0109	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000597	0.0104	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NARFL—glaucoma	0.000562	0.00975	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CA5A—glaucoma	0.000562	0.00975	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—GSTM1—glaucoma	0.000511	0.00886	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—CYP1B1—glaucoma	0.000511	0.00886	CbGpPWpGaD
Paricalcitol—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000504	0.00876	CbGpPWpGaD
Paricalcitol—CYP24A1—Metapathway biotransformation—GSTM1—glaucoma	0.000504	0.00874	CbGpPWpGaD
Paricalcitol—UGT1A4—Metapathway biotransformation—CYP1B1—glaucoma	0.000504	0.00874	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—GSTM1—glaucoma	0.000466	0.00808	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—FAS—glaucoma	0.000452	0.00785	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CA5A—glaucoma	0.000449	0.0078	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NARFL—glaucoma	0.000449	0.0078	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	0.000446	0.00775	CbGpPWpGaD
Paricalcitol—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000446	0.00774	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—BCL2L1—glaucoma	0.000427	0.00741	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—CAV1—glaucoma	0.000411	0.00714	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—GSTM1—glaucoma	0.000408	0.00709	CbGpPWpGaD
Paricalcitol—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000403	0.007	CbGpPWpGaD
Paricalcitol—UGT1A4—Metapathway biotransformation—GSTM1—glaucoma	0.000403	0.00699	CbGpPWpGaD
Paricalcitol—Malaise—Clonidine—glaucoma	0.000386	0.000618	CcSEcCtD
Paricalcitol—Mediastinal disorder—Betaxolol—glaucoma	0.000386	0.000618	CcSEcCtD
Paricalcitol—Dyspepsia—Pilocarpine—glaucoma	0.000386	0.000617	CcSEcCtD
Paricalcitol—Chills—Betaxolol—glaucoma	0.000385	0.000615	CcSEcCtD
Paricalcitol—Syncope—Clonidine—glaucoma	0.000384	0.000615	CcSEcCtD
Paricalcitol—Arrhythmia—Betaxolol—glaucoma	0.000383	0.000613	CcSEcCtD
Paricalcitol—Feeling abnormal—Dorzolamide—glaucoma	0.000382	0.000611	CcSEcCtD
Paricalcitol—Decreased appetite—Pilocarpine—glaucoma	0.000381	0.000609	CcSEcCtD
Paricalcitol—Feeling abnormal—Travoprost—glaucoma	0.00038	0.000608	CcSEcCtD
Paricalcitol—Conjunctivitis—Timolol—glaucoma	0.000379	0.000607	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Dorzolamide—glaucoma	0.000379	0.000606	CcSEcCtD
Paricalcitol—Alopecia—Betaxolol—glaucoma	0.000379	0.000606	CcSEcCtD
Paricalcitol—Palpitations—Clonidine—glaucoma	0.000379	0.000606	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000378	0.000605	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Travoprost—glaucoma	0.000377	0.000604	CcSEcCtD
Paricalcitol—Loss of consciousness—Clonidine—glaucoma	0.000377	0.000603	CcSEcCtD
Paricalcitol—Feeling abnormal—Brinzolamide—glaucoma	0.000376	0.000601	CcSEcCtD
Paricalcitol—Mental disorder—Betaxolol—glaucoma	0.000376	0.000601	CcSEcCtD
Paricalcitol—Pain—Pilocarpine—glaucoma	0.000375	0.000599	CcSEcCtD
Paricalcitol—Constipation—Pilocarpine—glaucoma	0.000375	0.000599	CcSEcCtD
Paricalcitol—Cough—Clonidine—glaucoma	0.000374	0.000598	CcSEcCtD
Paricalcitol—Sweating—Timolol—glaucoma	0.000374	0.000598	CcSEcCtD
Paricalcitol—Dizziness—Apraclonidine—glaucoma	0.000374	0.000598	CcSEcCtD
Paricalcitol—Malnutrition—Betaxolol—glaucoma	0.000373	0.000597	CcSEcCtD
Paricalcitol—Urticaria—Dorzolamide—glaucoma	0.000368	0.000589	CcSEcCtD
Paricalcitol—Epistaxis—Timolol—glaucoma	0.000368	0.000589	CcSEcCtD
Paricalcitol—Body temperature increased—Dorzolamide—glaucoma	0.000366	0.000586	CcSEcCtD
Paricalcitol—Abdominal pain—Dorzolamide—glaucoma	0.000366	0.000586	CcSEcCtD
Paricalcitol—Tension—Betaxolol—glaucoma	0.000366	0.000586	CcSEcCtD
Paricalcitol—Sinusitis—Timolol—glaucoma	0.000366	0.000585	CcSEcCtD
Paricalcitol—Dysgeusia—Betaxolol—glaucoma	0.000365	0.000584	CcSEcCtD
Paricalcitol—Chest pain—Clonidine—glaucoma	0.000365	0.000584	CcSEcCtD
Paricalcitol—Arthralgia—Clonidine—glaucoma	0.000365	0.000584	CcSEcCtD
Paricalcitol—Abdominal pain—Travoprost—glaucoma	0.000365	0.000584	CcSEcCtD
Paricalcitol—Anxiety—Clonidine—glaucoma	0.000364	0.000582	CcSEcCtD
Paricalcitol—Asthenia—Acetazolamide—glaucoma	0.000363	0.00058	CcSEcCtD
Paricalcitol—Dizziness—Bimatoprost—glaucoma	0.000362	0.00058	CcSEcCtD
Paricalcitol—Nervousness—Betaxolol—glaucoma	0.000362	0.00058	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000362	0.00058	CcSEcCtD
Paricalcitol—Urticaria—Brinzolamide—glaucoma	0.000362	0.000579	CcSEcCtD
Paricalcitol—Feeling abnormal—Pilocarpine—glaucoma	0.000361	0.000577	CcSEcCtD
Paricalcitol—Discomfort—Clonidine—glaucoma	0.00036	0.000577	CcSEcCtD
Paricalcitol—Vomiting—Apraclonidine—glaucoma	0.000359	0.000575	CcSEcCtD
Paricalcitol—Muscle spasms—Betaxolol—glaucoma	0.000359	0.000574	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Pilocarpine—glaucoma	0.000358	0.000573	CcSEcCtD
Paricalcitol—Hypersensitivity—Brimonidine—glaucoma	0.000358	0.000572	CcSEcCtD
Paricalcitol—Dry mouth—Clonidine—glaucoma	0.000357	0.000571	CcSEcCtD
Paricalcitol—Dermatitis—Apraclonidine—glaucoma	0.000356	0.00057	CcSEcCtD
Paricalcitol—Headache—Apraclonidine—glaucoma	0.000354	0.000567	CcSEcCtD
Paricalcitol—Confusional state—Clonidine—glaucoma	0.000353	0.000564	CcSEcCtD
Paricalcitol—Oedema—Clonidine—glaucoma	0.00035	0.00056	CcSEcCtD
Paricalcitol—Asthenia—Brimonidine—glaucoma	0.000348	0.000557	CcSEcCtD
Paricalcitol—Infection—Clonidine—glaucoma	0.000347	0.000556	CcSEcCtD
Paricalcitol—Abdominal pain—Pilocarpine—glaucoma	0.000346	0.000554	CcSEcCtD
Paricalcitol—Body temperature increased—Pilocarpine—glaucoma	0.000346	0.000554	CcSEcCtD
Paricalcitol—Ill-defined disorder—Betaxolol—glaucoma	0.000346	0.000554	CcSEcCtD
Paricalcitol—Diarrhoea—Acetazolamide—glaucoma	0.000346	0.000554	CcSEcCtD
Paricalcitol—Rash—Bimatoprost—glaucoma	0.000346	0.000553	CcSEcCtD
Paricalcitol—Dermatitis—Bimatoprost—glaucoma	0.000345	0.000552	CcSEcCtD
Paricalcitol—Oedema peripheral—Timolol—glaucoma	0.000345	0.000552	CcSEcCtD
Paricalcitol—Anaemia—Betaxolol—glaucoma	0.000345	0.000552	CcSEcCtD
Paricalcitol—Shock—Clonidine—glaucoma	0.000344	0.00055	CcSEcCtD
Paricalcitol—Connective tissue disorder—Timolol—glaucoma	0.000344	0.00055	CcSEcCtD
Paricalcitol—Pruritus—Brimonidine—glaucoma	0.000343	0.000549	CcSEcCtD
Paricalcitol—Headache—Bimatoprost—glaucoma	0.000343	0.000549	CcSEcCtD
Paricalcitol—Nervous system disorder—Clonidine—glaucoma	0.000343	0.000549	CcSEcCtD
Paricalcitol—Hypersensitivity—Dorzolamide—glaucoma	0.000342	0.000546	CcSEcCtD
Paricalcitol—Hypersensitivity—Travoprost—glaucoma	0.00034	0.000544	CcSEcCtD
Paricalcitol—Skin disorder—Clonidine—glaucoma	0.00034	0.000543	CcSEcCtD
Paricalcitol—Hyperhidrosis—Clonidine—glaucoma	0.000338	0.000541	CcSEcCtD
Paricalcitol—Malaise—Betaxolol—glaucoma	0.000336	0.000538	CcSEcCtD
Paricalcitol—Nausea—Apraclonidine—glaucoma	0.000336	0.000537	CcSEcCtD
Paricalcitol—Hypersensitivity—Brinzolamide—glaucoma	0.000336	0.000537	CcSEcCtD
Paricalcitol—Vertigo—Betaxolol—glaucoma	0.000335	0.000536	CcSEcCtD
Paricalcitol—Syncope—Betaxolol—glaucoma	0.000335	0.000535	CcSEcCtD
Paricalcitol—Dizziness—Acetazolamide—glaucoma	0.000334	0.000535	CcSEcCtD
Paricalcitol—Anorexia—Clonidine—glaucoma	0.000333	0.000533	CcSEcCtD
Paricalcitol—Asthenia—Dorzolamide—glaucoma	0.000333	0.000532	CcSEcCtD
Paricalcitol—VDR—Direct p53 effectors—MMP2—glaucoma	0.000332	0.00576	CbGpPWpGaD
Paricalcitol—Asthenia—Travoprost—glaucoma	0.000331	0.00053	CcSEcCtD
Paricalcitol—Palpitations—Betaxolol—glaucoma	0.00033	0.000527	CcSEcCtD
Paricalcitol—Pruritus—Dorzolamide—glaucoma	0.000328	0.000525	CcSEcCtD
Paricalcitol—Loss of consciousness—Betaxolol—glaucoma	0.000328	0.000525	CcSEcCtD
Paricalcitol—Eye disorder—Timolol—glaucoma	0.000327	0.000523	CcSEcCtD
Paricalcitol—Asthenia—Brinzolamide—glaucoma	0.000327	0.000523	CcSEcCtD
Paricalcitol—Hypotension—Clonidine—glaucoma	0.000327	0.000523	CcSEcCtD
Paricalcitol—Pruritus—Travoprost—glaucoma	0.000327	0.000522	CcSEcCtD
Paricalcitol—Cough—Betaxolol—glaucoma	0.000326	0.000521	CcSEcCtD
Paricalcitol—Nausea—Bimatoprost—glaucoma	0.000326	0.000521	CcSEcCtD
Paricalcitol—Cardiac disorder—Timolol—glaucoma	0.000325	0.00052	CcSEcCtD
Paricalcitol—Hypersensitivity—Pilocarpine—glaucoma	0.000323	0.000516	CcSEcCtD
Paricalcitol—Pruritus—Brinzolamide—glaucoma	0.000322	0.000516	CcSEcCtD
Paricalcitol—Vomiting—Acetazolamide—glaucoma	0.000322	0.000514	CcSEcCtD
Paricalcitol—Dizziness—Brimonidine—glaucoma	0.000321	0.000513	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Clonidine—glaucoma	0.000319	0.00051	CcSEcCtD
Paricalcitol—Angiopathy—Timolol—glaucoma	0.000318	0.000508	CcSEcCtD
Paricalcitol—Chest pain—Betaxolol—glaucoma	0.000318	0.000508	CcSEcCtD
Paricalcitol—Myalgia—Betaxolol—glaucoma	0.000318	0.000508	CcSEcCtD
Paricalcitol—Arthralgia—Betaxolol—glaucoma	0.000318	0.000508	CcSEcCtD
Paricalcitol—Diarrhoea—Dorzolamide—glaucoma	0.000317	0.000507	CcSEcCtD
Paricalcitol—Headache—Acetazolamide—glaucoma	0.000317	0.000507	CcSEcCtD
Paricalcitol—Anxiety—Betaxolol—glaucoma	0.000317	0.000506	CcSEcCtD
Paricalcitol—Insomnia—Clonidine—glaucoma	0.000316	0.000506	CcSEcCtD
Paricalcitol—Immune system disorder—Timolol—glaucoma	0.000316	0.000506	CcSEcCtD
Paricalcitol—Diarrhoea—Travoprost—glaucoma	0.000316	0.000505	CcSEcCtD
Paricalcitol—Mediastinal disorder—Timolol—glaucoma	0.000316	0.000505	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000315	0.000505	CcSEcCtD
Paricalcitol—Asthenia—Pilocarpine—glaucoma	0.000314	0.000503	CcSEcCtD
Paricalcitol—Paraesthesia—Clonidine—glaucoma	0.000314	0.000502	CcSEcCtD
Paricalcitol—Discomfort—Betaxolol—glaucoma	0.000314	0.000502	CcSEcCtD
Paricalcitol—Arrhythmia—Timolol—glaucoma	0.000313	0.0005	CcSEcCtD
Paricalcitol—Dyspnoea—Clonidine—glaucoma	0.000312	0.000499	CcSEcCtD
Paricalcitol—Diarrhoea—Brinzolamide—glaucoma	0.000312	0.000499	CcSEcCtD
Paricalcitol—Somnolence—Clonidine—glaucoma	0.000311	0.000497	CcSEcCtD
Paricalcitol—Dry mouth—Betaxolol—glaucoma	0.000311	0.000497	CcSEcCtD
Paricalcitol—Pruritus—Pilocarpine—glaucoma	0.00031	0.000496	CcSEcCtD
Paricalcitol—Alopecia—Timolol—glaucoma	0.000309	0.000495	CcSEcCtD
Paricalcitol—Confusional state—Betaxolol—glaucoma	0.000307	0.000491	CcSEcCtD
Paricalcitol—Mental disorder—Timolol—glaucoma	0.000307	0.000491	CcSEcCtD
Paricalcitol—Dizziness—Dorzolamide—glaucoma	0.000307	0.00049	CcSEcCtD
Paricalcitol—Rash—Brimonidine—glaucoma	0.000306	0.00049	CcSEcCtD
Paricalcitol—Dermatitis—Brimonidine—glaucoma	0.000306	0.000489	CcSEcCtD
Paricalcitol—Dizziness—Travoprost—glaucoma	0.000305	0.000488	CcSEcCtD
Paricalcitol—Malnutrition—Timolol—glaucoma	0.000305	0.000488	CcSEcCtD
Paricalcitol—Oedema—Betaxolol—glaucoma	0.000305	0.000487	CcSEcCtD
Paricalcitol—Headache—Brimonidine—glaucoma	0.000304	0.000486	CcSEcCtD
Paricalcitol—Decreased appetite—Clonidine—glaucoma	0.000304	0.000486	CcSEcCtD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000303	0.00526	CbGpPWpGaD
Paricalcitol—Infection—Betaxolol—glaucoma	0.000303	0.000484	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Clonidine—glaucoma	0.000302	0.000483	CcSEcCtD
Paricalcitol—Fatigue—Clonidine—glaucoma	0.000302	0.000482	CcSEcCtD
Paricalcitol—Dizziness—Brinzolamide—glaucoma	0.000301	0.000482	CcSEcCtD
Paricalcitol—Nausea—Acetazolamide—glaucoma	0.0003	0.000481	CcSEcCtD
Paricalcitol—Diarrhoea—Pilocarpine—glaucoma	0.0003	0.000479	CcSEcCtD
Paricalcitol—Shock—Betaxolol—glaucoma	0.0003	0.000479	CcSEcCtD
Paricalcitol—Tension—Timolol—glaucoma	0.000299	0.000478	CcSEcCtD
Paricalcitol—Pain—Clonidine—glaucoma	0.000299	0.000478	CcSEcCtD
Paricalcitol—Constipation—Clonidine—glaucoma	0.000299	0.000478	CcSEcCtD
Paricalcitol—Nervous system disorder—Betaxolol—glaucoma	0.000299	0.000478	CcSEcCtD
Paricalcitol—Dysgeusia—Timolol—glaucoma	0.000298	0.000477	CcSEcCtD
Paricalcitol—Nervousness—Timolol—glaucoma	0.000296	0.000474	CcSEcCtD
Paricalcitol—Skin disorder—Betaxolol—glaucoma	0.000296	0.000473	CcSEcCtD
Paricalcitol—Vomiting—Dorzolamide—glaucoma	0.000295	0.000471	CcSEcCtD
Paricalcitol—Hyperhidrosis—Betaxolol—glaucoma	0.000294	0.000471	CcSEcCtD
Paricalcitol—Rash—Dorzolamide—glaucoma	0.000292	0.000468	CcSEcCtD
Paricalcitol—Dermatitis—Dorzolamide—glaucoma	0.000292	0.000467	CcSEcCtD
Paricalcitol—Rash—Travoprost—glaucoma	0.000291	0.000466	CcSEcCtD
Paricalcitol—Dermatitis—Travoprost—glaucoma	0.000291	0.000465	CcSEcCtD
Paricalcitol—Headache—Dorzolamide—glaucoma	0.00029	0.000465	CcSEcCtD
Paricalcitol—Anorexia—Betaxolol—glaucoma	0.00029	0.000464	CcSEcCtD
Paricalcitol—Vomiting—Brinzolamide—glaucoma	0.00029	0.000463	CcSEcCtD
Paricalcitol—Dizziness—Pilocarpine—glaucoma	0.00029	0.000463	CcSEcCtD
Paricalcitol—Headache—Travoprost—glaucoma	0.000289	0.000463	CcSEcCtD
Paricalcitol—Nausea—Brimonidine—glaucoma	0.000288	0.000461	CcSEcCtD
Paricalcitol—Feeling abnormal—Clonidine—glaucoma	0.000288	0.000461	CcSEcCtD
Paricalcitol—Rash—Brinzolamide—glaucoma	0.000287	0.00046	CcSEcCtD
Paricalcitol—Dermatitis—Brinzolamide—glaucoma	0.000287	0.000459	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Clonidine—glaucoma	0.000286	0.000458	CcSEcCtD
Paricalcitol—Headache—Brinzolamide—glaucoma	0.000285	0.000457	CcSEcCtD
Paricalcitol—Hypotension—Betaxolol—glaucoma	0.000285	0.000455	CcSEcCtD
Paricalcitol—Angioedema—Timolol—glaucoma	0.000279	0.000446	CcSEcCtD
Paricalcitol—Vomiting—Pilocarpine—glaucoma	0.000278	0.000445	CcSEcCtD
Paricalcitol—Urticaria—Clonidine—glaucoma	0.000278	0.000444	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000277	0.000444	CcSEcCtD
Paricalcitol—Abdominal pain—Clonidine—glaucoma	0.000277	0.000442	CcSEcCtD
Paricalcitol—Body temperature increased—Clonidine—glaucoma	0.000277	0.000442	CcSEcCtD
Paricalcitol—Rash—Pilocarpine—glaucoma	0.000276	0.000442	CcSEcCtD
Paricalcitol—Dermatitis—Pilocarpine—glaucoma	0.000276	0.000441	CcSEcCtD
Paricalcitol—Insomnia—Betaxolol—glaucoma	0.000275	0.000441	CcSEcCtD
Paricalcitol—Nausea—Dorzolamide—glaucoma	0.000275	0.00044	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—CA1—glaucoma	0.000274	0.00476	CbGpPWpGaD
Paricalcitol—Headache—Pilocarpine—glaucoma	0.000274	0.000439	CcSEcCtD
Paricalcitol—Nausea—Travoprost—glaucoma	0.000274	0.000439	CcSEcCtD
Paricalcitol—Vertigo—Timolol—glaucoma	0.000274	0.000438	CcSEcCtD
Paricalcitol—Paraesthesia—Betaxolol—glaucoma	0.000273	0.000437	CcSEcCtD
Paricalcitol—Syncope—Timolol—glaucoma	0.000273	0.000437	CcSEcCtD
Paricalcitol—Dyspnoea—Betaxolol—glaucoma	0.000271	0.000434	CcSEcCtD
Paricalcitol—Nausea—Brinzolamide—glaucoma	0.000271	0.000433	CcSEcCtD
Paricalcitol—Palpitations—Timolol—glaucoma	0.000269	0.000431	CcSEcCtD
Paricalcitol—Dyspepsia—Betaxolol—glaucoma	0.000268	0.000429	CcSEcCtD
Paricalcitol—Loss of consciousness—Timolol—glaucoma	0.000268	0.000429	CcSEcCtD
Paricalcitol—Cough—Timolol—glaucoma	0.000266	0.000425	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—CTSA—glaucoma	0.000266	0.00461	CbGpPWpGaD
Paricalcitol—Decreased appetite—Betaxolol—glaucoma	0.000265	0.000423	CcSEcCtD
Paricalcitol—Hypertension—Timolol—glaucoma	0.000263	0.000421	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Betaxolol—glaucoma	0.000263	0.000421	CcSEcCtD
Paricalcitol—Fatigue—Betaxolol—glaucoma	0.000263	0.00042	CcSEcCtD
Paricalcitol—Constipation—Betaxolol—glaucoma	0.00026	0.000417	CcSEcCtD
Paricalcitol—Pain—Betaxolol—glaucoma	0.00026	0.000417	CcSEcCtD
Paricalcitol—Nausea—Pilocarpine—glaucoma	0.00026	0.000416	CcSEcCtD
Paricalcitol—Myalgia—Timolol—glaucoma	0.00026	0.000415	CcSEcCtD
Paricalcitol—Chest pain—Timolol—glaucoma	0.00026	0.000415	CcSEcCtD
Paricalcitol—Arthralgia—Timolol—glaucoma	0.00026	0.000415	CcSEcCtD
Paricalcitol—Anxiety—Timolol—glaucoma	0.000259	0.000414	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000258	0.000412	CcSEcCtD
Paricalcitol—Hypersensitivity—Clonidine—glaucoma	0.000258	0.000412	CcSEcCtD
Paricalcitol—Discomfort—Timolol—glaucoma	0.000256	0.00041	CcSEcCtD
Paricalcitol—Dry mouth—Timolol—glaucoma	0.000254	0.000406	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—CA2—glaucoma	0.000251	0.00436	CbGpPWpGaD
Paricalcitol—Asthenia—Clonidine—glaucoma	0.000251	0.000401	CcSEcCtD
Paricalcitol—Feeling abnormal—Betaxolol—glaucoma	0.000251	0.000401	CcSEcCtD
Paricalcitol—Confusional state—Timolol—glaucoma	0.000251	0.000401	CcSEcCtD
Paricalcitol—Oedema—Timolol—glaucoma	0.000249	0.000398	CcSEcCtD
Paricalcitol—Pruritus—Clonidine—glaucoma	0.000247	0.000396	CcSEcCtD
Paricalcitol—Infection—Timolol—glaucoma	0.000247	0.000395	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000245	0.00426	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000245	0.00426	CbGpPWpGaD
Paricalcitol—Shock—Timolol—glaucoma	0.000245	0.000392	CcSEcCtD
Paricalcitol—Nervous system disorder—Timolol—glaucoma	0.000244	0.00039	CcSEcCtD
Paricalcitol—Urticaria—Betaxolol—glaucoma	0.000242	0.000387	CcSEcCtD
Paricalcitol—Skin disorder—Timolol—glaucoma	0.000242	0.000387	CcSEcCtD
Paricalcitol—Body temperature increased—Betaxolol—glaucoma	0.000241	0.000385	CcSEcCtD
Paricalcitol—Hyperhidrosis—Timolol—glaucoma	0.00024	0.000385	CcSEcCtD
Paricalcitol—Diarrhoea—Clonidine—glaucoma	0.000239	0.000383	CcSEcCtD
Paricalcitol—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000238	0.00413	CbGpPWpGaD
Paricalcitol—Anorexia—Timolol—glaucoma	0.000237	0.000379	CcSEcCtD
Paricalcitol—Hypotension—Timolol—glaucoma	0.000232	0.000372	CcSEcCtD
Paricalcitol—Dizziness—Clonidine—glaucoma	0.000231	0.00037	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Timolol—glaucoma	0.000227	0.000363	CcSEcCtD
Paricalcitol—Insomnia—Timolol—glaucoma	0.000225	0.00036	CcSEcCtD
Paricalcitol—Hypersensitivity—Betaxolol—glaucoma	0.000224	0.000359	CcSEcCtD
Paricalcitol—Paraesthesia—Timolol—glaucoma	0.000223	0.000357	CcSEcCtD
Paricalcitol—Vomiting—Clonidine—glaucoma	0.000222	0.000356	CcSEcCtD
Paricalcitol—Dyspnoea—Timolol—glaucoma	0.000222	0.000355	CcSEcCtD
Paricalcitol—Somnolence—Timolol—glaucoma	0.000221	0.000354	CcSEcCtD
Paricalcitol—Rash—Clonidine—glaucoma	0.000221	0.000353	CcSEcCtD
Paricalcitol—Dermatitis—Clonidine—glaucoma	0.00022	0.000352	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—CA1—glaucoma	0.000219	0.00381	CbGpPWpGaD
Paricalcitol—Headache—Clonidine—glaucoma	0.000219	0.000351	CcSEcCtD
Paricalcitol—Dyspepsia—Timolol—glaucoma	0.000219	0.00035	CcSEcCtD
Paricalcitol—Asthenia—Betaxolol—glaucoma	0.000218	0.00035	CcSEcCtD
Paricalcitol—Decreased appetite—Timolol—glaucoma	0.000216	0.000346	CcSEcCtD
Paricalcitol—Pruritus—Betaxolol—glaucoma	0.000215	0.000345	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Timolol—glaucoma	0.000215	0.000344	CcSEcCtD
Paricalcitol—Fatigue—Timolol—glaucoma	0.000214	0.000343	CcSEcCtD
Paricalcitol—Pain—Timolol—glaucoma	0.000213	0.00034	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—CTSA—glaucoma	0.000213	0.00369	CbGpPWpGaD
Paricalcitol—Diarrhoea—Betaxolol—glaucoma	0.000208	0.000333	CcSEcCtD
Paricalcitol—Nausea—Clonidine—glaucoma	0.000208	0.000332	CcSEcCtD
Paricalcitol—VDR—Generic Transcription Pathway—CDKN2B—glaucoma	0.000206	0.00358	CbGpPWpGaD
Paricalcitol—Feeling abnormal—Timolol—glaucoma	0.000205	0.000328	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Timolol—glaucoma	0.000203	0.000325	CcSEcCtD
Paricalcitol—Dizziness—Betaxolol—glaucoma	0.000201	0.000322	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—CA2—glaucoma	0.000201	0.00348	CbGpPWpGaD
Paricalcitol—Urticaria—Timolol—glaucoma	0.000198	0.000316	CcSEcCtD
Paricalcitol—Body temperature increased—Timolol—glaucoma	0.000197	0.000315	CcSEcCtD
Paricalcitol—Abdominal pain—Timolol—glaucoma	0.000197	0.000315	CcSEcCtD
Paricalcitol—Vomiting—Betaxolol—glaucoma	0.000194	0.00031	CcSEcCtD
Paricalcitol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000193	0.00334	CbGpPWpGaD
Paricalcitol—Rash—Betaxolol—glaucoma	0.000192	0.000307	CcSEcCtD
Paricalcitol—Dermatitis—Betaxolol—glaucoma	0.000192	0.000307	CcSEcCtD
Paricalcitol—Headache—Betaxolol—glaucoma	0.000191	0.000305	CcSEcCtD
Paricalcitol—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.00019	0.0033	CbGpPWpGaD
Paricalcitol—Hypersensitivity—Timolol—glaucoma	0.000183	0.000293	CcSEcCtD
Paricalcitol—VDR—Generic Transcription Pathway—NR3C1—glaucoma	0.000181	0.00314	CbGpPWpGaD
Paricalcitol—Nausea—Betaxolol—glaucoma	0.000181	0.000289	CcSEcCtD
Paricalcitol—Asthenia—Timolol—glaucoma	0.000178	0.000286	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—TXN—glaucoma	0.000177	0.00307	CbGpPWpGaD
Paricalcitol—Pruritus—Timolol—glaucoma	0.000176	0.000282	CcSEcCtD
Paricalcitol—Diarrhoea—Timolol—glaucoma	0.00017	0.000272	CcSEcCtD
Paricalcitol—VDR—Direct p53 effectors—TP53—glaucoma	0.000169	0.00294	CbGpPWpGaD
Paricalcitol—Dizziness—Timolol—glaucoma	0.000165	0.000263	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000161	0.0028	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.00016	0.00277	CbGpPWpGaD
Paricalcitol—Vomiting—Timolol—glaucoma	0.000158	0.000253	CcSEcCtD
Paricalcitol—Rash—Timolol—glaucoma	0.000157	0.000251	CcSEcCtD
Paricalcitol—Dermatitis—Timolol—glaucoma	0.000157	0.000251	CcSEcCtD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000156	0.00271	CbGpPWpGaD
Paricalcitol—Headache—Timolol—glaucoma	0.000156	0.000249	CcSEcCtD
Paricalcitol—Nausea—Timolol—glaucoma	0.000148	0.000236	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—TXN—glaucoma	0.000141	0.00245	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GSTT1—glaucoma	0.000137	0.00238	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	0.000111	0.00192	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GSTT1—glaucoma	0.00011	0.0019	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ABCA1—glaucoma	0.000109	0.0019	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CYP1B1—glaucoma	0.000109	0.0019	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—GSTT1—glaucoma	0.000104	0.00181	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—CDKN2B—glaucoma	9.93e-05	0.00172	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ABCA1—glaucoma	8.74e-05	0.00152	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CYP1B1—glaucoma	8.74e-05	0.00152	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GSTM1—glaucoma	8.74e-05	0.00152	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—NR3C1—glaucoma	8.71e-05	0.00151	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—CYP1B1—glaucoma	8.29e-05	0.00144	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	8.18e-05	0.00142	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—MTHFR—glaucoma	7.72e-05	0.00134	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CA5A—glaucoma	7.29e-05	0.00127	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NARFL—glaucoma	7.29e-05	0.00127	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—APOE—glaucoma	7.19e-05	0.00125	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CAV1—glaucoma	7.12e-05	0.00124	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GSTM1—glaucoma	6.98e-05	0.00121	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—GSTM1—glaucoma	6.63e-05	0.00115	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	6.54e-05	0.00113	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—MTHFR—glaucoma	6.17e-05	0.00107	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—APOE—glaucoma	5.75e-05	0.000997	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CAV1—glaucoma	5.69e-05	0.000988	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NOS3—glaucoma	5.38e-05	0.000934	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PTGS2—glaucoma	4.92e-05	0.000855	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NOS3—glaucoma	4.3e-05	0.000747	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PTGS2—glaucoma	3.94e-05	0.000683	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CA1—glaucoma	3.56e-05	0.000618	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CTSA—glaucoma	3.45e-05	0.000599	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CA2—glaucoma	3.26e-05	0.000565	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—TXN—glaucoma	2.3e-05	0.000398	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTT1—glaucoma	1.78e-05	0.000309	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP1B1—glaucoma	1.42e-05	0.000246	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ABCA1—glaucoma	1.42e-05	0.000246	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTM1—glaucoma	1.13e-05	0.000197	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—MTHFR—glaucoma	1e-05	0.000174	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—APOE—glaucoma	9.33e-06	0.000162	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CAV1—glaucoma	9.24e-06	0.00016	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NOS3—glaucoma	6.99e-06	0.000121	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PTGS2—glaucoma	6.39e-06	0.000111	CbGpPWpGaD
